Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Creative Medical Technology Holdings, Inc. (CELZ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3300-0.0200 (-0.85%)
At close: 04:00PM EST
2.3900 +0.06 (+2.58%)
After hours: 07:17PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close2.3500
Open2.3400
Bid2.3300 x 1000
Ask2.3500 x 1000
Day's Range2.1500 - 2.5299
52 Week Range1.5825 - 65.0000
Volume861,027
Avg. Volume2,224,103
Market Cap14.743M
Beta (5Y Monthly)4.65
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CELZ

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Creative Medical Technology Hol
    Analyst Report: QIAGEN N.V.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
All
News
Press Releases
Advertisement
Advertisement